Literature DB >> 8214067

Prostaglandin modulation of the gastric vasculature and mucosal integrity in cirrhotic rats.

P L Beck1, W McKnight, S S Lee, J L Wallace.   

Abstract

Gastric bleeding is a frequent occurrence in cirrhotic patients and may be related to altered microcirculatory responses to luminal irritants and/or vasoactive mediators. Because gastric prostaglandin synthesis has been reported to be altered in cirrhosis, we have examined the role of prostaglandins in modulating gastric perfusion velocity and mucosal integrity in cirrhotic rats. Cirrhosis was induced by bile duct ligation. Gastric perfusion velocity was measured in an ex vivo gastric chamber preparation by laser-Doppler flowmetry. The responsiveness of the mucosa to topical application of 20% ethanol was assessed. Effects of pretreatment with indomethacin or misoprostol were also determined. Gastric and hepatic prostaglandin E2 syntheses were significantly depressed (by approximately 60%) in cirrhotic vs. normal rats. Administration of indomethacin (7.5 mg/kg) to normal rats did not significantly affect gastric perfusion velocity, but in cirrhotic rats it caused a 45% reduction (P < 0.05). Topically applied misoprostol produced significantly greater (2- to 5-fold) increases in gastric perfusion velocity in cirrhotics than in controls. Cirrhotic rats were significantly more susceptible to gastric injury induced by topically applied 20% ethanol than were controls. These results suggest that gastric perfusion velocity in cirrhotic rats is modulated by endogenous prostaglandins to a much greater degree than in controls. Gastric vascular hyperresponsiveness to misoprostol may be attributable to an adaptive response to depressed endogenous prostaglandin synthesis in the cirrhotic animals.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8214067     DOI: 10.1152/ajpgi.1993.265.3.G453

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  6 in total

Review 1.  Portal hypertensive gastropathy and gastric antral vascular ectasia (GAVE) syndrome.

Authors:  K W Burak; S S Lee; P L Beck
Journal:  Gut       Date:  2001-12       Impact factor: 23.059

2.  Portal hypertensive gastropathy: A systematic review of the pathophysiology, clinical presentation, natural history and therapy.

Authors:  Mihajlo Gjeorgjievski; Mitchell S Cappell
Journal:  World J Hepatol       Date:  2016-02-08

3.  Cytoprotective activity in the gastric mucosa of rats exposed to carbon tetrachloride-induced liver injury.

Authors:  O Bulbena; J Culat; M L Bravo
Journal:  Inflammation       Date:  1997-10       Impact factor: 4.092

Review 4.  Hydrogen sulfide chemical biology: pathophysiological roles and detection.

Authors:  Gopi K Kolluru; Xinggui Shen; Shyamal C Bir; Christopher G Kevil
Journal:  Nitric Oxide       Date:  2013-07-09       Impact factor: 4.427

Review 5.  Pathogenesis of portal hypertensive gastropathy: translating basic research into clinical practice.

Authors:  Rafael F Perini; Paula R S Camara; Jose G P Ferraz
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2009-02-03

6.  The diminished expression of proangiogenic growth factors and their receptors in gastric ulcers of cirrhotic patients.

Authors:  Jiing-Chyuan Luo; Yen-Ling Peng; Ming-Chih Hou; Kuang-Wei Huang; Hui-Chun Huang; Ying-Wen Wang; Han-Chieh Lin; Fa-Yauh Lee; Ching-Liang Lu
Journal:  PLoS One       Date:  2013-04-19       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.